Beximco Pharmaceuticals Limited (BXP.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 25.87B |
| Enterprise Value | 31.04B |
| P/E Ratio | 5.29 |
| PEG Ratio | 0.18 |
| Price/Sales Ratio | 0.69 |
| Price/Book Ratio | 0.64 |
| Enterprise/Revenue | 0.81 |
| Enterprise/EBITDA | 3.38 |
Fiscal Year
| Fiscal Year | June 30, 2024 |
| Most Recent Quarter | December 31, 2024 |
Profitability
| Profit Margin | 0.13 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 44.39B |
| Revenue/Share | 99.51 |
| Gross Profit | 19.63B |
| EBITDA | 10.64B |
| Net Income | 5.83B |
| Diluted EPS | 13.07 |
Balance Sheet
| Total Cash | 2.36B |
| Total Cash/Share | 2.36 |
| Total Debt | 6.19B |
| Total Debt/Equity | 0.13 |
| Current Ratio | 2.18 |
| Book Value Per Share | 116.35 |
Price History
| 52-Week Change | 10.39 |
| 52-Week High | 52.33 |
| 52-Week Low | 0.43 |
| Moving Average 50 Days | 27.54 |
| Moving Average 200 Days | 37.89 |
Statistics
| Average Volume | 47,382 |
| Shares Outstanding | 446.11M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.27 |
| Last Split Factor | 11:10 |
| Last Split Date | November 23, 2020 |
AD
